Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged ≥55 years

Drugs and Aging

Volumn 25, Issue 2, 2008, Pages 145-152

  Becker, Matthijs L ^a   Visser, Loes E ^a   Van Gelder, Teun ^a   Hofman, Albert ^a   Stricker, Bruno H Ch ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Drug Safety Unit   (Netherlands)

Author keywords

Drug interactions; Elderly; Spironolactone, therapeutic use

Indexed keywords

ALDOSTERONE RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; ANTIVITAMIN K; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; PROPAFENONE; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; SPIRONOLACTONE; THYROID HORMONE; TRAZODONE; VERAPAMIL;

ARTICLE; GERIATRIC CARE; HUMAN; MEDICAL SOCIETY; PHARMACY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 38949181992     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825020-00006     Document Type: Article

References (23)

1. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36 (9): 1331-6
2. Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Pharmacother 2003; 37 (1): 5-11
3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004; 329 (7456): 15-9
4. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289 (13): 1652-8
5. Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004; 351 (11): 1089-96
6. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57 (2): 121-6
7. Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21 (4): 294-300
8. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44 (8): 944-8
9. Merlo J, Liedholm H, Lindblad U, et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001; 323 (7310): 427-8
10. Bergendal L, Friberg A, Schaffrath A. Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. Pharm World Sci 1995; 17 (5): 152-7
11. Bjerrum L, Andersen M, Petersen G, et al. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003; 21 (3): 153-8
12. Borkman IK, Fastbom J, Schmidt IK, et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36 (11): 1675-81
13. Braverman SE, Howard RS, Bryant PR, et al. Potential drug interactions in a physical medicine and rehabilitation clinic. Am J Phys Med Rehabil 1996; 75 (1): 44-9
14. Linnarsson R. Drug interactions in primary health care: a retrospective database study and its implications for the design of a computerized decision support system. Scand J Prim Health Care 1993; 11 (3): 181-6
15. Hofman A, Grobbee DE, de Jong PT, et al. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7 (4): 403-22
16. van Roon EN, Flikweert S, le Comte M, et al. Clinical relevance of drug-drug interactions: a structured assessment procedure. Drug Saf 2005; 28 (12): 1131-9
17. WINAp. G-standaard, Kombi-ROM. Den Haag: WINAp, 2006
18. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failauthors ure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341 (10): 709-17
19. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351 (6): 543-51
20. Stockley IH. Stockley's drug interactions: a source book of interactions, their mechanisms, clinical importance and management. 6th ed. London: Pharmaceutical Press, 2002
21. Johnson AG. NSAIDs and increased blood pressure. What is the clinical significance? Drug Saf 1997; 17 (5): 277-89
22. Radley AS, Fitzpatrick RW. An evaluation of the potential interaction between enalapril and amiloride. J Clin Pharm Ther 1987; 12 (5): 319-23
23. Koffer H, Vlasses PH, Ferguson RK, et al. Captopril in diuretictions treated hypertensive patients. JAMA 1980; 244 (22): 2532-5